Cardiovascular Events in Cancer Patients Treated with Highly or Moderately Emetogenic Chemotherapy: Results from a Population-Based Study

Studies on cardiovascular safety in cancer patients treated with highly or moderately emetogenic chemotherapy (HEC or MEC), who may have taken the antiemetic, aprepitant, have been limited to clinical trials and postmarketing spontaneous reports. Our study explored background rates of cardiovascular...

Descripción completa

Detalles Bibliográficos
Autores principales: Vo, Thao T., Nelson, Jeanenne J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335187/
https://www.ncbi.nlm.nih.gov/pubmed/22570656
http://dx.doi.org/10.1155/2012/529357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335187/
https://www.ncbi.nlm.nih.gov/pubmed/22570656
http://dx.doi.org/10.1155/2012/529357

Ejemplares similares